Comparison
46 Xy Sex Reversal 6 C3151064 vs 4q25 Proximal Deletion Syndrome
Clinical comparison between 46 XY Sex Reversal 6 and 4q25 Proximal Deletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
46 Xy Sex Reversal 6 C3151064
0-0
4q25 Proximal Deletion Syndrome
Variable
Onset patterns differ
Severity
46 Xy Sex Reversal 6 C3151064
severe
4q25 Proximal Deletion Syndrome
moderate
Different severity levels
Chronic
46 Xy Sex Reversal 6 C3151064
Chronic
4q25 Proximal Deletion Syndrome
Chronic
Differing course
Communicable
46 Xy Sex Reversal 6 C3151064
No
4q25 Proximal Deletion Syndrome
No
Different transmission
Body System
46 Xy Sex Reversal 6 C3151064
reproductive
4q25 Proximal Deletion Syndrome
congenital
Same/different system
Category
46 Xy Sex Reversal 6 C3151064
genetic
4q25 Proximal Deletion Syndrome
genetic
Different category
Bottom line
46-xy-sex-reversal-6-C3151064 and 4q25-proximal-deletion-syndrome-C5680087 differ in severity
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Sex Reversal 6 C3151064 | 4q25 Proximal Deletion Syndrome | Discriminating power |
|---|---|---|---|
| Sex development | XY chromosomes with female or atypical genital development, per supplied description. | Sex-development findings are not established from the available data. | High |
| Onset | Congenital, with onset recorded as birth. | Onset is listed as variable; exact timing is not established. | Moderate |
| Associated congenital features | Primarily framed as a reproductive genetic condition. | Congenital genetic syndrome, but organ involvement is not specified. | Moderate |
When to favor each condition
Choose 46 Xy Sex Reversal 6 C3151064 when
XY karyotype with atypical or female genital development
This matches the supplied description of sex reversal.
High
Evaluation centers on sex development
The left concept is assigned to the reproductive system.
Moderate
No evidence of a 4q25 deletion
Absence of that chromosomal finding makes the deletion syndrome less applicable.
Moderate
Choose 4q25 Proximal Deletion Syndrome when
Genetic testing identifies a proximal 4q25 deletion
The diagnosis depends on the chromosomal finding rather than phenotype alone.
High
Presentation is congenital but not limited to sex development
The supplied axis places it in a broader congenital category.
Low
Sex-chromosome findings do not explain the presentation
Alternative chromosomal testing may be considered by a clinician.
Low
How key tests differ
| Test | 46 Xy Sex Reversal 6 C3151064 | 4q25 Proximal Deletion Syndrome | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY is central to the concept. | Sex-chromosome result is not established. | A 46,XY result supports the left concept but does not exclude other diagnoses. |
| Chromosomal microarray | A 4q25 deletion is not part of the supplied definition. | Proximal 4q25 deletion is the defining finding. | Laboratory confirmation and clinician review are required. |
| Sex-development gene testing | May investigate genes involved in sex development. | No specific gene result is established here. | Testing choice should be individualized; no cutoff is implied. |
Prognosis comparison
46 Xy Sex Reversal 6 C3151064
- Outcome
- Chronic congenital condition; exact outcome is not established.
- Factors
- Specific genetic finding, anatomy, and endocrine assessment.
4q25 Proximal Deletion Syndrome
- Outcome
- Listed as moderate and chronic, but outcome data are sparse.
- Factors
- Deletion extent, affected systems, and developmental findings.
Time frame: Lifelong, with needs potentially changing over time.
No mortality or prevalence estimate is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Reproductive implications | Potential implications for genital development and fertility require specialist assessment. Reproductive effects are not established. Do not infer fertility or treatment needs from these labels. |
| Developmental impact | Not established beyond the sex-development description. Possible but unspecified because source data are sparse. Developmental surveillance should follow clinical findings. |
| Associated anomalies | Not specified in the supplied data. Not specified despite a congenital classification. Imaging or referrals should be based on examination, not assumptions. |
Patient education highlights
- HighDiagnosis versus test result
A chromosomal or genetic result needs clinician interpretation and does not by itself determine care.
- HighIndividual variation
Features, severity, and needs can vary; sparse data should not be treated as a complete prognosis.
- MediumSpecialist follow-up
Genetics and, when relevant, sex-development specialists can explain results and options.